Nordic Cell Therapy Group is a specialized cell therapy company providing cell therapy consulting, CMC strategy, analytics, and therapeutic development across the full lifecycle of advanced cell therapies
‍
We support biotech companies, academic groups, and industry partners in advancing cell therapy programs from early discovery to clinical and commercial readiness.
‍
Our expertise spans scientific strategy, process and CMC development, analytical solutions, and therapeutic innovation, grounded in real-world experience from complex cell therapy programs.
‍
We have contributed to the design, development, and advancement of cell-based therapies, helping partners navigate key challenges in development, scalability, and translation to the clinic.
‍
Through three complementary divisions, Consulting, Analytics, and Ventures, we combine external collaboration with internal therapeutic development to accelerate the next generation of regenerative medicines.‍